Clinical Trials Search Results

Page 2 of 2 | Results 11 - 13 of 13

Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in high risk HER2-positive patients with residual invasive breast cancer following neoadjuvant therapy

Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy are at higher...
Breast Cancer
Joseph Kash, MD

Edward Cancer Center - Naperville
Edward Cancer Center - Plainfield
Nancy Knowles Cancer Center - Elmhurst

Accepting Participants

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study

Maria Quejada, MD

Edward Cancer Center - Naperville
Edward Cancer Center - Plainfield
Nancy Knowles Cancer Center - Elmhurst

Accepting Participants

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Myelomonocytic Leukemia
Matthew Siegel, MD

Edward Cancer Center - Naperville
Nancy Knowles Cancer Center - Elmhurst

Accepting Participants
Page 2 of 2 | Results 11 - 13 of 13